Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

References

+
+
AbuRahma  AF, Yacoub  M. Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography. Semin Vasc Surg. 2013;26:134–43.  [PubMed: 25220318]
+
+
Anderson  JL, Halperin  JL, Albert  NM  et al. Management of patients with PAD (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;127:1425–43.  [PubMed: 23457117]
+
+
Bavishi  C, de Leeuw  PW, Messerli  FH. Atherosclerotic renal artery stenosis and hypertension: pragmatism, pitfalls, and perspectives. Am J Med. 2016;129:635.e5–635.e14.
+
+
Charles  L, Triscott  J, Dobbs  B. Secondary hypertension: discovering the underlying cause. Am Fam Physician. 2017;96:453–61.  [PubMed: 29094913]
+
+
Fugate  JE, Rabinstein  AA. Posterior reversible encephalopathy syndrome: clinical and radiologic manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14:914–25.  [PubMed: 26184985]
+
+
Funder  JW, Carey  RM, Mantero  F  et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocinol Metab. 2016;101:1889–916.
+
+
Grundy  SM, Stone  NJ, Bailey  AL,  et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. November 10, 2018.
+
+
Kline  GA, Prebtani  APH, Leung  AA, Schiffrin  EL. Primary aldosteronism: a common cause of resistant hypertension. CMAJ. 2017;189:E773–8.  [PubMed: 28584041]
+
+
Lenders  JW, Duh  QY, Eisenhofer  G  et al. Pheochromocytoma and paraganglionoma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.  [PubMed: 24893135]
+
+
Manger  WM, Gifford  RW. Pheochromocytoma. J Clin Hypertension. 2002;4:62–72.
+
+
Pappachan  JM, Raskauskiene  D, Sriraman  R  et al. Diagnosis and management of pheochromocytoma: a practical guide to clinicians. Curr Hypertens Rep. 2014;16:442.  [PubMed: 24792093]
+
+
Patel  KK, Young  L, Howell  EH  et al. Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med. 2016;176:981–8.  [PubMed: 27294333]
+
+
Rimoldi  SF, Scherrer  U, Messerli  FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014;35:1245–54.  [PubMed: 24366917]
+
+
Simel  DL, Wong  CL, Holroyd-Leduc  J  et al. Update: paracentesis. In: Simel  DL, Rennie  D, eds. The Rational Clinical Examination: Evidence-Based Clinical Diagnosis. New York, NY: McGraw-Hill; 2013. https://jamaevidence.mhmedical.com/content.aspx?bookid=845&sectionid=61357445. Accessed 5/1/2018.
+
+
Suneja  M, Sanders  ML. Hypertensive emergency. Med Clin North Am. 2017;101:465–78.  [PubMed: 28372707]
+
+
Taler  SJ. Initial treatment of hypertension. N Engl J Med. 2018;378:636–44.  [PubMed: 29443671]
+
+
Textor  SC. Renal arterial disease and hypertension. Med Clin North Am. 2017;101:65–79.  [PubMed: 27884236]
+
+
van Berkel  A, Lenders  JW, Timmers  HJ. Diagnosis of endocrine disease: biochemical diagnosis of phaeochromocytoma and paraganglionoma. Eur J Endocrinol. 2014;170:R109–19.  [PubMed: 24347425]
+
+
Van de Ven  PJG, Beutler  JJ, Kaatee  R  et al. Angiotensin converting enzyme inhibitor induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 1998;53:986–93.  [PubMed: 9551408] ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MH Privacy Center Close